• Accessibility

Unmatched Clinical Research

More peer-reviewed papers, clinical trials, and patents than anyone in digital health. See the science behind better care.

Line chart comparing total publications across companies from 2015 to 2026, with Sword showing the highest growth and leading total.

Image description

Chart Description: Total Publications (2016 - 2026)

Overview: A line chart illustrating the "Total Publications" over a 10-year period, from prior to 2016 through 2026. The chart highlights the growth of an entity named "Sword" (represented by a thick blue line) against eight other unnamed or partially named entities (represented by thin gray lines), such as "lyra".

Axes:

  • X-axis (Horizontal): Represents time in years, with markers for 2016, 2018, 2020, 2022, 2024, and 2026.

  • Y-axis (Vertical): Represents "Total Publications" starting at 0 and going up to 60, with tick marks at 0, 15, 30, 45, and 60.

Primary Data Trend ("Sword"): The highlighted blue line for "Sword" shows continuous, exponential growth over the decade, significantly outperforming all other entities.

  • 2016: Starts relatively low, at approximately 5 publications.

  • 2018: Grows steadily to roughly 12-14 publications.

  • 2020: Reaches approximately 20 publications.

  • 2022: Experiences a sharp upward curve, hitting 30 publications.

  • 2024: Continues steep growth, reaching approximately 48-50 publications.

  • 2026: Plateaus just below the maximum y-axis value, ending at roughly 58 publications.

Secondary Data Trends (Competitors): Eight thin gray lines represent other entities. While their specific data points are not individually labeled, the overall visual comparison shows:

  • All competitors start near zero publications around 2015/2016.

  • By 2026, the highest-performing competitor reaches only about 35 publications (roughly half of Sword's total).

  • The second-highest reaches approximately 25 publications.

  • The remaining six entities show very slow growth, all remaining below 15 total publications by 2026, with several plateauing near zero.

Groundbreaking innovation

Unwavering clinical integrity

We are committed to providing high-quality, evidence-based care and to continuously validating and enhancing our care models through rigorous clinical research and innovation.

Our approach

AI Care done right

Developing leading solutions requires a comprehensive framework that reinvents care from the ground up

Getting the core principles right

All of Sword’s programs begin with an in-depth research of the latest and most solid clinical evidence, to determine the core foundations that we need to build.

A woman in a navy polo shirt works on a laptop, surrounded by illustrated documents, representing the concept of research.

Embedding clinical insights in product development

At Sword, clinicians and researchers work side by side with engineering and product to ensure our solutions are built on top of strong clinical foundations and truly answer the needs of our members.

A person exercises in front of a smartphone camera, which displays a skeleton overlay for motion tracking and a score of 9/10 at the bottom. Arrows and curved lines labeled Research and Create surround the phone.

Uncompromising clinical rigour

Our solutions are thoroughly validated through a two-tiered approach consisting of controlled trials against high-quality, in-person care and real-world evidence generation.

A woman in workout clothes stands with one knee raised, hands on hips, and smiles. White lines and dots outline her body’s joints and posture. Surrounding text reads: Research, Create, and Clinical trials.

No regulatory shortcuts

All our solutions are assessed against the stringent criteria of FDA and other regulated bodies, and certification is pursued for all software and hardware that falls within the scope of medical devices.

A circular diagram with four stages: Research, Create, Clinical trials, and Certification. Centered are certification logos: HITRUST, FDA, HIPAA Compliant, CE, and AICPA SOC 2.

Continuous improvement mindset

After launching, we continuously monitor engagement and clinical outcomes, as well feedback from members and clinicians, to further improve our solutions, in order to help more and more members becoming free of pain.

An older woman exercises indoors, mirroring a younger woman on a screen. Around them, a circular diagram shows the stages: Research, Create, Clinical trials, Certification, and Launch.

Explore Sword’s clinical studies

Clinical board

Our Clinical Advisory Board

Advancing equity

Care that benefits your entire population equitably

As a leader in the digital health space, we have the responsibility and the opportunity to build a more equitable, inclusive future—one in which high‑quality care is accessible to everyone, regardless of their circumstances. 

Our research proves that we are:

  • Driving higher engagement and similar outcomes in members living in rural vs. urban areas1

  • Addressing the needs of older adults2

  • Delivering stellar clinical outcomes in members from different racial and ethnic backgrounds3

  • Equally benefiting members from all socioeconomic backgrounds4

No other digital company in this space is backed by as much research in DE&I as Sword.

Six women stand together indoors, smiling at the camera. They are dressed in smart-casual attire, with a modern office space and hanging plants in the background.

Put your members in the safest hands

HIPAA
HiTrust
SOC 2
CE

A better future

Funding research in the pain field

We know we can’t build a more equitable future alone. Which is why the Sword Foundation recognizes the most groundbreaking scientific work in the pain field each year with the Horizon Award.

Learn more
A person in a dark sweater holds a translucent pink and blue rectangular award that reads “Horizon Award, Sword Foundation, May 2024,” with “Presented to Christophe Gauy-Sabourin” engraved at the bottom.

Featured stories

Want to advance research with us?

Contact us

Footnotes

  1. 1

    JMIR Mhealth Uhealth 2023;11:e44316 doi: 10.2196/44316

  2. 2

    JMIR Rehabil Assist Technol 2023;10:e49673 doi: 10.2196/49673

  3. 3

    J Med Internet Res 2022;24(10):e41306 doi: 10.2196/41306

  4. 4

    npj Digit. Med. 6, 188 (2023). https://doi.org/10.1038/s41746-023-00936-2

Portugal 2020Norte 2020European UnionPlano de Recuperação e ResiliênciaRepública PortuguesaNext Generation EU
Project_20812
Project_23655
Project_37596
Project_46516
Project_49222
Project_QRAC
Project_PRR62